Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE: Validation of PROs in MAC Lung Infection
NCT04677543Phase 3Completed
- Sponsor
- Insmed Incorporated
- Start
- Dec 2020
- Primary completion
- May 2023
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 12
01
Overview
A Phase 3 trial of amikacin liposome inhalation suspension in Mycobacterium avium complex lung infection, sponsored by Insmed Incorporated. Started Dec 2020; status: completed.
02
Drugs
amikacin liposome inhalation suspension
03
Conditions
Mycobacterium avium complex lung infection
Beyond the preview
Go deeper on NCT04677543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677543.